Postmenopausal Gout: What Really Happens When Estrogen Disappears

The Numbers Are Startling

A 67-year-old woman walks into her doctor’s office with a swollen knee. She’s been told it’s osteoarthritis for the third time. It’s not. It’s gout, and she’s part of a trend that researchers are calling a wake-up call.

Here’s what a Lancet Rheumatology systematic review published in 2026 revealed: global hyperuricemia prevalence in women jumped from 6.7% in 2000 to 11.2% by 2023. That’s a 67% increase in just over two decades. The number of women living with elevated uric acid more than doubled, from 126 million to 305 million worldwide.

Men still have higher rates overall. But the rate at which women are catching up is what has researchers concerned.

Why Estrogen Matters More Than You Think

Most people know estrogen for its role in reproduction. What far fewer understand is that this same hormone directly influences how well your kidneys clear uric acid.

Think of your kidneys as a sorting facility. Every day, they process uric acid and decide what stays and what goes. Two proteins handle the heavy lifting: URAT1 and GLUT9. These sit in your kidney tubules and basically control whether uric acid gets flushed out in urine or reabsorbed back into your bloodstream.

Estrogen suppresses these reabsorbing proteins. When estrogen is present, your kidneys do a better job of pushing uric acid out. When it’s gone, URAT1 and GLUT9 become more active, and your kidneys start holding onto uric acid instead of excreting it.

During reproductive years, this estrogen effect keeps women’s average serum uric acid around 4.2 mg/dL, compared to about 5.2 mg/dL in men. That 1 mg/dL gap might sound small, but it’s the difference between crystal formation and no crystal formation for a lot of people.

The Timeline: What Happens When Estrogen Drops

A 2026 study published in Arthritis & Rheumatology tracked 8,169 Japanese women over a median of 13.8 years, with annual exams spanning premenopause through postmenopause. The findings paint a clear picture of what happens during the transition.

Serum uric acid levels rose gradually during premenopause, then shot up sharply during perimenopause, and finally stabilized at a higher level in postmenopause. Compared to premenopause, the average uric acid level was 0.41 mg/dL higher after menopause.

Hyperuricemia prevalence went from less than 1% before menopause to 4-5% after. And for women who were overweight at the time of menopause, that number jumped to roughly 18%.

The transition isn’t subtle. It’s a measurable shift that happens over a relatively short window.

By 70, the Gender Gap Nearly Disappears

Before menopause, women account for only about 5% of newly diagnosed gout cases. The male-to-female ratio is steep, roughly 3:1 or 4:1 in younger adults.

But that ratio shrinks with age. A UK study found that in adults over 70, the male-to-female ratio for gout drops to just 2.3:1. By age 60, women account for about 50% of new gout diagnoses. By age 80, some data suggest more women than men develop gout.

South Korea offers another data point. The country’s gout cases surged 80% over the past decade, from roughly 308,000 in 2014 to 553,000 in 2024. Female patients with gout in their 40s numbered only 4,870, but this rose to 8,629 in their 60s and 6,760 in their 70s, according to national health insurance data.

So the trajectory is clear: the protection estrogen provides is real, but temporary. Once it’s gone, women’s uric acid levels and gout risk begin climbing toward men’s.

Why Postmenopausal Gout Looks Different

If you’re a woman who develops gout after menopause, your experience will likely differ from the classic “man’s disease” presentation in several ways.

First, the joints. Men typically get hit in the big toe first. Women are more likely to have their first attack in fingers, wrists, or knees. A hand gout episode in a 65-year-old woman gets dismissed as osteoarthritis more often than anyone would like to admit.

Second, comorbidities. Women with gout tend to have more accompanying conditions than men: hypertension, chronic kidney disease, diabetes. These aren’t just extra diagnoses on your chart. They complicate treatment, because some common gout medications interact poorly with reduced kidney function.

Third, diuretics. Women are prescribed diuretics for blood pressure and heart conditions at higher rates than men, especially after menopause. Loop and thiazide diuretics both raise uric acid by interfering with kidney excretion. If you’re taking a blood pressure pill that’s a diuretic, it could be working against you.

The result? Delayed diagnosis, more joint damage before treatment starts, and more frustration for women who’ve been told “it’s probably just arthritis.”

The Nurses’ Health Study: 92,000 Women, 16 Years

The Nurses’ Health Study followed over 92,000 women for 16 years, and the findings remain some of the most cited data on menopause and gout.

Menopause itself increased gout risk by about 26%, independent of body weight, blood pressure, diet, and other factors. But the details matter:

• Surgical menopause (both ovaries removed) carried the highest risk, because hormone loss is sudden rather than gradual.
• Women who went through natural menopause before age 45 had a 62% higher gout risk compared to those who hit menopause between 50 and 54.
• Women using hormone replacement therapy showed an 18% lower gout risk than those who didn’t.

The Third National Health and Nutrition Examination Survey (NHANES III) added another layer. After adjusting for age, weight, kidney function, and other variables, postmenopausal women had uric acid levels roughly 0.34 to 0.36 mg/dL higher than premenopausal women. Current hormone users had levels about 0.24 mg/dL lower.

What You Can Actually Do About It

Knowing that estrogen loss drives uric acid up doesn’t mean you’re powerless. It means you need to act earlier and more deliberately than you might have thought.

Get your uric acid checked. If you’re approaching menopause or already past it, ask your doctor for a serum uric acid test. The numbers are straightforward to read, and catching high levels before your first attack is far easier than managing gout after it starts.

Review your medications. If you’re on diuretics for blood pressure, talk to your doctor about alternatives. Angiotensin-converting enzyme (ACE) inhibitors and losartan have uric acid-neutral or even uric acid-lowering effects, unlike thiazide diuretics.

Watch your weight. The 2026 Japanese study found that being overweight at menopause was associated with hyperuricemia in about 18% of women. Maintaining a healthy body mass index (BMI) before and during the menopausal transition may reduce postmenopausal risk significantly.

Limit fructose. Sugar-sweetened beverages are a stronger driver of gout in women than alcohol. A large study of women found that those who drank two or more sugary drinks per day had a significantly higher risk of gout, even after controlling for other factors.

Stay hydrated. Simple, but uric acid is excreted through urine. Less urine means more uric acid stays in your blood. Aim for enough water that your urine is pale yellow.

FAQ

Does every woman get gout after menopause?

No. While the risk increases after menopause, most postmenopausal women do not develop gout. Hyperuricemia prevalence reaches about 11% globally, and not everyone with elevated uric acid develops gout. Genetics, diet, weight, kidney function, and medication use all play a role.

Can hormone replacement therapy prevent gout?

HRT is associated with about an 18% lower gout risk in observational studies. But HRT carries its own risks, including increased risk of blood clots, stroke, and certain cancers. The decision to use HRT should involve a careful conversation with your doctor weighing all benefits and risks, not just gout prevention.

Why do women get gout in their hands instead of their big toe?

The reasons aren’t fully understood, but women are more likely to have existing joint changes in their hands from osteoarthritis, which may create an environment where uric acid crystals deposit more easily. Hand involvement is also one reason gout gets misdiagnosed as osteoarthritis or rheumatoid arthritis in women.

At what uric acid level should postmenopausal women start treatment?

Most guidelines consider a serum uric acid above 6.8 mg/dL as the threshold for hyperuricemia. However, treatment decisions depend on whether you’ve had a gout attack, whether you have tophi, and your overall cardiovascular and kidney risk profile. Some doctors may recommend lifestyle changes at lower levels before starting medication.

Is postmenopausal gout more dangerous than gout in men?

Women with gout tend to have more comorbidities and higher mortality risk than men with gout, according to several studies. This is partly because women develop gout later in life when other health conditions have already taken hold, and partly because delayed diagnosis allows more joint damage to accumulate. Early detection matters.

Reviewed by the GoutSavvy Editorial Team